Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS

Oral Surgery, Oral Medicine, Oral Pathology

Volumn 67, Issue 4, 1989, Pages 427-432

  MacPhail, Laurie A ^a   Greenspan, Deborah ^a   Schiødt, Morten ^a   Drennan, David P ^b   Mills, John ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CASE REPORT; DRUG RESISTANCE; HERPES LABIALIS; HERPES SIMPLEX VIRUS 2; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MOUTH DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; CANDIDIASIS, ORAL; CASE REPORT; DRUG RESISTANCE, MICROBIAL; FACIAL DERMATOSES; FOSCARNET; HERPES SIMPLEX; HUMAN; MALE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONOACETIC ACID; STOMATITIS, HERPETIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024555290     PISSN: 00304220     EISSN: None     Source Type: Journal    
DOI: 10.1016/0030-4220(89)90386-1     Document Type: Article

References (35)

1. Skin infections
2. Infections with herpes simplex viruses
3. Infections with herpes simplex viruses
4. Antiviral therapy in the immunocompromised patient
5. Prospective study of prevalence, incidence, and source of herpesvirus infections in patients with renal allografts
6. Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation
7. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant
8. The incidence of oral herpes simplex virus infection in patients undergoing cancer chemotherapy
9. Severe acquired immunodeficiency in male homosexuals manifested by chronic perianal ulcerative herpes simplex lesions
10. Chronic perianal herpes simplex in immunocompromised hosts
11. Chronic oral herpes simplex virus infection in immunocompromised patients
12. Isolation and characterization of resistant herpes simplex virus after acyclovir therapy
13. Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir
14. Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child
15. In vitro sensitivity to acyclovir in genital herpes simplex viruses from acyclovir-treated patients
16. Virus resistance in clinical practice
17. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir
18. Suppression of frequently recurring genital herpes
19. Characterization of acyclovir-resistant and -sensitive herpes simplex viruses isolated from a patient with an acquired immune deficiency
20. Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS
21. Acyclovir resistance in a patient with chronic mucocutaneous herpes simplex infection
22. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome
23. Disseminated herpes simplex type 2 and systemic Candida infection in a patient with previous asymptomatic human immunodeficiency virus infection
24. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)-guanine
25. The biochemistry and mechanism of action of acyclovir
26. History, pharmacokinetics, and pharmacology of acyclovir
27. Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates
28. Recurrent genital herpes and suppressive oral acyclovir therapy
29. Significance of resistance of herpes simplex virus to acyclovir
30. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity
31. Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase
32. Antiviral effects of phosphonoformate (PFA foscarnet sodium)
33. Pharmacokinetics, safety, and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients
34. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (foscarnet)
35. Acyclovir-resistant herpes in AIDS treated with foscarnet